Expand Oracle Contracting beyond its legacy blood plasma portfolio by building relationships with national healthcare providers, franchise organizations, retail brands, and commercial clients, creating a diversified pipeline of recurring construction opportunities.
After years of success in the blood plasma sector, Oracle Contracting partnered with Ideal Rev to diversify its business development strategy and expand into new commercial markets.
Rather than pursuing one-off projects, the focus shifted to building long-term relationships with organizations executing multi-location expansion, renovations, tenant improvements, and capital improvement programs.
Relationship-Driven Outreach — Built direct relationships with executives responsible for construction, facilities, development, and capital projects, creating opportunities before projects reached the public bid stage.
Strategic Market Targeting — Developed a targeted pipeline of national healthcare providers, franchise organizations, retail brands, and commercial clients with recurring construction programs, positioning Oracle Contracting as a long-term construction partner rather than a transactional bidder.
The relationship-building strategy continues to generate opportunities across multiple commercial sectors, including:
• Ground-up multifamily development opportunity currently under evaluation.
• Active discussions with national healthcare and veterinary organizations executing multi-location expansion programs.
• Ongoing conversations with franchise operators and retail brands planning future renovations and tenant improvements.
• Continued expansion opportunities within existing client accounts, creating additional repeat business beyond initial project awards.
With more than $6.3 million in awarded work and an expanding pipeline that now includes healthcare, veterinary, franchise retail, and ground-up multifamily opportunities, Oracle Contracting is well positioned for continued growth through a diversified, relationship-driven business development strategy.